Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124941) titled 'A Cross-Sectional Study on Nutrition and Developmental Risks of Children A... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124944) titled 'Ropeginterferon Alfa-2b for High-Risk Smoldering Multiple Myeloma??' on Ma... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124947) titled 'The Effects of Surgical and Occlusal Splint Treatment on Bone Remodeling ... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124950) titled 'Prognostic Prediction of Hepatocellular Carcinoma Invasiveness Based on CE... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124953) titled 'Construction of a Risk-Stratified Personalized Bowel Preparation Regimen f... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124956) titled 'Effects of COVID-19 Vaccination, Microplastic and PFAS Exposure on COVID-1... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124962) titled 'Cohort Study on Chronic Non-communicable Diseases among Healthy Physical E... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124969) titled 'Study on the selection pathway of peripheral venous access for perioperati... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124877) titled 'A Study on the Precision Diagnosis of Prostate Cancer Using Multi-Paramete... Read More
Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124881) titled 'Trastuzumab Rezetecan Antibody-Drug Conjugate Combined with Retlirafusp a ... Read More